Navigation Links
Medical Device Industry Veteran Angela Horacek Joins AlloSource as VP of Operations

CENTENNIAL, Colo., April 13, 2011 /PRNewswire/ -- AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of live cellular bone growth substitutes, today announced the hire of Angela Horacek as the Vice President, Operations.

In this role Horacek, a seasoned medical device and operations expert, will oversee the broad range of AlloSource operations including donor receiving and medical records clearance, as well as tissue processing and release.

"It is with great pleasure that we welcome Angela to the AlloSource Executive Leadership Team, where her industry experience, strategic operational thought process and exceptional rapport with people will be great assets for our organization," said Thomas Cycyota, president and CEO of AlloSource. "We are dedicated to advancing the possibilities of tissue transplantation to better serve patients and honor the brave gift of life from donors and their families, and Angela's expertise will help us support this goal."

Horacek comes to AlloSource from nSpire Health, a leading developer and manufacturer of respiratory care products, where she was most recently the Global Vice President of Operations and Quality.  In this role, Horacek was responsible for manufacturing, supply chain, logistics, facilities and quality and regulatory services for three facilities around the world. Prior to her role at nSpire Health, she held positions of increasing responsibility in operations for several medical device and pharmaceutical organizations.  

Horacek holds a bachelor's degree in chemical engineering, a MBA from the University of Louisiana in Lafayette, and a master's degree in Conflict Resolution from the University of Denver.

AlloSource, a nonprofit organization and one of the nation's premier tissue networks, has provided a range of tissue allografts including bone, skin and joint grafts to its local communities around the country for more than fifteen years. The Company has recently expanded into osteobiologics offerings, which help to stimulate natural bone formation, and has pioneered the use of mesenchymal stem cells derived from donor adipose tissue for orthopedic applications. AlloSource has facilitated approximately 100,000 live stem cell transplants worldwide, becoming the world's largest provider of stem cell tissue for surgeries.  

About AlloSource

AlloSource delivers powerful possibilities to the medical community, patients and donor families. AlloSource is a non-profit company that offers more than 200 precise bone, skin, soft-tissue and custom-machined allografts for use in a host of life-saving and life-enhancing medical procedures. As the world's leader in fresh cartilage tissue used for joint repair and skin allografts to heal severe burns, AlloSource has become one of the largest and most respected tissue networks in the country. It is also the world's largest processor of live cellular bone growth substitutes. AlloSource delivers unparalleled expertise and responsive customer service to its growing network of surgeons, partners and the country's most reputable organ procurement organizations. AlloSource is accredited by the American Association of Tissue Banks (AATB) and operates in Centennial, CO. For more information, visit

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Thomas Cycyota

SOURCE AlloSource
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the ... medical article to the newly revamped Cosmetic Town journal section, featuring ... transplant procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
Breaking Medicine News(10 mins):